Scale up of a elimination program and Plasmodium falciparum

Myanmar has one of the largest malaria burdens in Southeast Background: Asia. Along the border with Thailand, parasites are Plasmodium falciparum increasingly showing reduced sensitivity to artemisinin combination therapies. Given that there are no current alternative treatment therapies, one proposed solution to the threat of untreatable malaria is to eliminate the P. falciparum parasite from the region. Several small-scale elimination projects have been piloted along the Myanmar-Thailand border. Following their success, this operational research aimed to scale up the elimination to a broad area of Eastern Kayin State, Myanmar. The project relied on geographic reconnaissance and a geographic Methods: information system, community engagement, generalized access to community-based early diagnosis and treatment, near real-time epidemiological surveillance, cross sectional malaria prevalence surveys and targeted mass drug administration in villages with high prevalence of P. malaria. Molecular markers of drug resistance were also monitored falciparum in individuals with symptomatic and asymptomatic infections. This project illustrates the establishment of an elimination project Discussion: and operational research in a remote, rural area encompassing several armed groups, multiple political organizations and a near-absent health care infrastructure. The establishment of the project relied on a strong rapport with the target community, on-the-ground knowledge (through geographic surveys and community engagement), rapid decision making and an approach that was flexible enough to quickly adapt to a complex landscape. The elimination project is ongoing, now over three years in operation, and assessment of the impact of this operational research will follow. This project has relevance not only for other malaria elimination projects but also for operational research aimed at eliminating other diseases. 1* 1* 1 1

[1]  L. Rénia,et al.  Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar , 2017, Wellcome open research.

[2]  J. McCarthy,et al.  Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge Infections , 2017, The American journal of tropical medicine and hygiene.

[3]  F. Nosten,et al.  Community engagement for the rapid elimination of malaria: the case of Kayin State, Myanmar , 2017, Wellcome open research.

[4]  D. Kwiatkowski,et al.  Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. , 2017, The Lancet. Infectious diseases.

[5]  Phubeth Ya-umphan,et al.  Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border , 2016, The Journal of infectious diseases.

[6]  D. Kwiatkowski,et al.  Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration , 2016, Malaria Journal.

[7]  F. Nosten,et al.  The acceptability mass administrations of anti-malarial drug as part of targeted malaria elimination in villages along the Thai–Myanmar border , 2016, Malaria Journal.

[8]  Gil McVean,et al.  Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum , 2016, Genome research.

[9]  Alistair Miles,et al.  Genomic analysis of local variation and recent evolution in Plasmodium vivax , 2016, Nature Genetics.

[10]  L. Rénia,et al.  The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand–Myanmar border areas, Cambodia, and Vietnam , 2015, Malaria Journal.

[11]  Francois Nosten,et al.  Elimination of Plasmodium falciparum in an area of multi-drug resistance , 2015, Malaria Journal.

[12]  Shui-sen Zhou,et al.  Operational research on malaria control and elimination: a review of projects published between 2008 and 2013 , 2014, Malaria Journal.

[13]  D. Kwiatkowski,et al.  Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.

[14]  Nicholas P. J. Day,et al.  High-Throughput Ultrasensitive Molecular Techniques for Quantifying Low-Density Malaria Parasitemias , 2014, Journal of Clinical Microbiology.

[15]  S. Manguin Anopheles mosquitoes : New insights into malaria vectors , 2013 .

[16]  John C. Tan,et al.  Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing , 2012, Nature.

[17]  F. Nosten,et al.  Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.

[18]  Caroline W. Kabaria,et al.  The dominant Anopheles vectors of human malaria in the Asia-Pacific region: occurrence data, distribution maps and bionomic précis , 2011, Parasites & Vectors.

[19]  Justin M. Cohen,et al.  Operational strategies to achieve and maintain malaria elimination , 2010 .

[20]  Nancy F. Hansen,et al.  Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.

[21]  G. Snounou,et al.  Development of a Real-Time PCR Assay for Detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for Routine Clinical Diagnosis , 2004, Journal of Clinical Microbiology.

[22]  T. Oo BIOLOGY AND VECTOR COMPETENCE OF THE ANOPHELINE MOSQUITOES OF MYANMAR WITH SPECIAL CONSIDERATION OF ANOPHELES DIRUS , 2003 .